Anzeige
17.11.2016 | Research Article
Efficacy and safety of JAK inhibitor INC424 in patients with primary and post-polycythemia vera or post-essential thrombocythemia myelofibrosis in the Chinese population
Erschienen in: Frontiers of Medicine | Ausgabe 4/2016
Einloggen, um Zugang zu erhalten